EXCLUSIVE: Sen. Katie Britt’s new family initiative leans on TrumpRx to deliver lower-cost fertility drugs for families
Sen. Katie Britt (R-Ala.) is once again at the center of one of the Trump administration’s biggest family policy rollouts, and at the heart of her new effort is TrumpRx, the direct-to-consumer drug pricing platform that Republicans have made the cornerstone of their affordability agenda.
Britt joined President Donald Trump in the Oval Office on Monday to launch Moms.gov, a new Department of Health and Human Services site that went live on Mother’s Day. The site is a clearinghouse of resources for expecting and new mothers, covering nutrition, breastfeeding, mental health, adoption, and the administration’s new “Trump Accounts” savings program for newborns. It also directs Americans seeking IVF and fertility medication straight to TrumpRx.gov, where patients can purchase those drugs at steeply discounted prices.
That last piece is a quietly significant policy expansion. IVF and fertility drugs have long been among the most expensive out-of-pocket medications in the country, with a single round of treatment often running into five figures before insurance. By routing patients to TrumpRx, the administration is folding fertility care into the same negotiated-discount model that has already delivered savings of up to 80 percent on other branded prescriptions through deals with major pharmaceutical manufacturers.
“President Trump knows moms are the heartbeats of our families, our communities, and our country,” Britt said at the Oval Office event. “He’s made sure that we have created a comprehensive culture of life. That’s what you see with Moms.gov.”
Trump credited Britt with originating the project. “She’s the one that got me into this, I have to tell you,” the president said during the press conference.
Britt has been working on the idea for two years through her MOMS Act, legislation she has carried since 2024 with cosponsors including then-Sen. Marco Rubio (R-Fla.), Sen. Kevin Cramer (R-N.D.), and Sen. Eric Schmitt (R-Mo.). The bill called for a federal clearinghouse of resources for expecting mothers. Moms.gov is the administrative realization of that vision.
The fertility-and-IVF angle slots Britt’s project into a growing Republican story on affordability. CMS Administrator Mehmet Oz and HHS Secretary Robert F. Kennedy Jr. joined Britt at the rollout, both emphasizing the broader administration push to lower the cost of building a family. Trump’s TrumpRx program has already drawn praise from Senate Majority Whip John Barrasso (R-Wyo.), Sen. Eric Schmitt, Sen. Roger Marshall (R-Kan.), Rep. Andy Barr (R-Ky.), Rep. Tim Moore (R-N.C.), and Rep. Mike Haridopolos (R-Fla.), among others. Adding IVF and fertility medication to the platform extends the political reach of the program into one of the most economically painful corners of American health care.
For Britt, who has built one of the fastest-rising profiles in the Senate Republican Conference, Moms.gov fuses two of her signature issues: support for mothers and Trump-era affordability wins.
